0
Article Tier 2 Sign in to save

The Plastic Within: Micro- and Nanoplastics in Human Tissues and the Nutritional Context for Exposure Mitigation

AI summary Read the abstract

This narrative review covers detections of micro- and nanoplastics in human blood, lung, placenta, artery plaque, brain, liver and testicular tissue. The strongest human signal is one observational cohort linking plastics in artery plaque to later cardiovascular events (hazard ratio 4.53). Evidence on diet and nutrition in this context is described as limited.

Background: Microplastics (MPs) and nanoplastics (NPs) are increasingly detected in human tissues, prompting concern about potential biological effects. Yet, for most outcomes, the literature remains dominated by detection studies and preclinical toxicology, with limited human dose-response data. Methods: We conducted a narrative review of peer-reviewed literature (2000-2025), prioritizing human biomonitoring and tissue-detection studies, observational health-outcome studies, and mechanistic evidence that plausibly links exposure to cardiometabolic, reproductive, and neuroinflammatory pathways. Certainty of evidence was appraised using GRADE principles where applicable and explicitly separated from mechanistic plausibility. Results: MPs/NPs have been reported in blood, lung, placenta, atherosclerotic plaques, brain, liver, and testicular tissue. The most clinically salient human outcome signal to date is an association between plaque microplastics and subsequent major adverse cardiovascular events in an observational cohort (hazard ratio 4.53, 95% CI 2.00-10.27). However, polymer quantification approaches vary (particle counts vs polymer mass), contamination control is method-dependent, and inter-study comparability remains limited. Conclusion: The current evidence base supports aggressive exposure reduction as the most defensible "first-line" strategy. Nutritional approaches (dietary fiber, gut-barrier support, and microbiome modulation) are best framed as adjunctive, mechanistically plausible risk-mitigation strategies rather than proven methods to remove plastics from the body. Well-designed human trials and standardized analytical protocols are needed before clinical "detoxification" claims can be justified.

More Papers Like This

Article Tier 2

Micro and Nano-plastic particles: What are they and do they effect cardiovascular health?

AI summary Read the abstract

This review examines the cardiovascular health effects of micro- and nanoplastics, summarizing evidence that these particles have been detected in human tissues including arterial plaques and may promote endothelial dysfunction and inflammation. The authors call for further clinical and epidemiological research into cardiac risk.

Clinical Trial Tier 1

Microplastic and Nanoplastic Contamination as a Novel Cardiovascular Risk Factor: A Narrative Review of Pathophysiological Mechanisms and Public Health Consequences

AI summary Read the abstract

This review pulls together existing research on tiny plastic particles found in our blood, organs, and even artery plaque. One study found people with these plastics in their artery plaque had a much higher risk of heart attack, stroke, or death. Scientists think the plastics may cause harmful inflammation and cell damage, though more research is needed to confirm this causes heart disease.

Article Tier 2

Micro- and Nanoplastics in Cardiovascular Toxicology: Human Tissue Detection, Clinical Phenotypes, and Adverse Outcome Signals

AI summary Read the abstract

Scientists are finding tiny plastic particles (called micro- and nanoplastics) lodged in human blood, arteries, and even fatty plaque buildup in blood vessels — and one major study found people with plastic particles in their neck artery plaque were over 4 times more likely to have a heart attack, stroke, or die during follow-up. This review pulls together lab and human research showing these plastics may cause inflammation, blood clotting, and heart tissue damage, though scientists stress this doesn't yet prove plastics *cause* heart disease — it shows a concerning link that deserves more attention and research.

Article Tier 2

Evidence, Mechanisms, and Clinical Implications of Microplastics and Nanoplastics As Emerging Cardiovascular Risk Factors: A Narrative Review

AI summary Read the abstract

This review examines growing evidence that micro- and nanoplastics may contribute to cardiovascular health risks, with researchers having found these particles in human artery plaques and blood clots. Evidence indicates that the particles can enter the bloodstream, trigger inflammation, damage blood vessel walls, and potentially increase the risk of heart attacks and strokes. While the evidence is not yet conclusive, the study highlights an emerging area of concern that warrants further investigation into how everyday plastic exposure may affect heart and blood vessel health.

Article Tier 2

Micro- and nanoplastics as emerging cardiovascular risk factors: a new atherogenic player?

AI summary Read the abstract

This review summarizes existing research on tiny plastic particles called microplastics and nanoplastics, which are found in food, water, and human tissue. It reports that these particles may contribute to clogged, hardened arteries by causing cell stress, inflammation, and blood vessel problems, though current evidence does not prove they cause heart disease in people.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper